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Background:  Recent data suggest that statins may attenuate exercise training (ET) response, but limited data exist in patients with heart 
failure (HF), many of whom use statins.
methods:  HF-ACTION was a randomized, controlled (usual care vs ET) trial of 2,331 chronic ambulatory HF patients with ejection fraction 
≤ 35%. We evaluated whether there was a treatment interaction between statins and ET response measured by peak oxygen consumption 
(VO2) and 6-minute walk distance (6MWD) from baseline to 3 months. Multiple regression analyses were performed for each endpoint, 
adjusting for baseline measures and previously identified HF-ACTION risk model covariates. We also assessed for a differential treatment 
interaction between atorvastatin, simvastatin, pravastatin and ET.
results:  Of 1,353 patients in HF-ACTION with documented statin use, 670 (49.5%) were randomized to ET and 683 (50.5%) to usual 
care. Patients treated with statins were more likely to be older men with hypertension, ischemic etiology, elevated BUN and lower heart 
rate. Patients randomized to ET vs usual care had a larger increase in peak VO2 (0.6 vs 0.2 ml/kg/min, p<0.001) and 6MWD (20 vs 5 m, p 
0.05) (Table).
conclusion:  In this large trial of ET in patients with chronic HF, there was no evidence of an interaction between statin use and short-term 
change in exercise capacity.
 
